DaptomycinImmuneSafety Rating 8/10

Primary research areaComplicated skin infections

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range4-6 mg/kg once daily IV
AdministrationIntravenous
Safety8/10 · FDA-approved (Cubicin)
NCAA D1Permitted

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Daptomycin

Mechanism of action

Cyclic lipopeptide antibiotic; calcium-dependent membrane insertion disrupts bacterial membrane potential

Safety profile

Myopathy (monitor CPK weekly), eosinophilic pneumonia, GI effects · Approved for serious infections; monitor CPK; eosinophilic pneumonia rare; well-characterized

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Daptomycin

Failed to fetch